At last, Dharmanol Citrolene™, the genie in a bottle that

New Post Public Reply Private Reply Replies (0) Message Board

Feb 28, 2014 at 10:14 AM

At last, Dharmanol Citrolene™, the genie in a bottle that is Big Pharma's worst nightmare.

(Marketwired) - 02/28/14 - Medical Greens, a subsidiary of SK3 Group (OTC Pink: SKTO) is seeking qualified California medical marijuana patients to receive a free sample of its new, non-psychoactive medical cannabis product, Dharmanol Citrolene, developed by its Berkeley Bio-Organic Research Laboratory.

Containing many of the medicinal elements of medical marijuana in their non-psychoactive form, Dharmanol Citrolene provides many of the benefits that scientists are ascribing to medical cannabis, without the high associated with eating or smoking marijuana.

Dharmanol Citrolene contains CBD, a non-psychoactive "chemical cousin" to THC, the element in marijuana that makes people high or stoned. In addition, it contains phyto-cannabinoids in their non-psychoactive carboxylate form. It also contains d-limonene, a medicinal element found in cannabis, known as a terpene.

D-limonene has been shown to have a relaxing, anti-anxiety, anti-spasmodic effect. This is because it binds to the same receptors in the human body as do the pharmaceutical synthetics Valium and Xanax. Dharmanol Citrolene contains a healthy dose of organically-sourced d-limonene. Although the d-limonene used in Dharmanol Citrolene is chemically identical to that produced by the cannabis/hemp plant, it is actually sourced from the rind of citrus fruits.

Interestingly, research has shown d-limonene to have many properties that are similar to cannabis in their interaction with cancer. Sloan Kettering Cancer Center lists 19 very promising studies using this powerful natural medicine.

mskcc.org/cancer-care/herb/d-limonene

To participate in the Company's survey, an individual must be a medical cannabis patient with a valid physician recommendation and live in the State of California in one of the zip codes currently served by Pharmajanes.com. To see if you qualify, go to the website and check out the section labeled "Dharmanol Citrolene Promotion." Starting this upcoming Wednesday, March 5, 2014, individuals requesting the promotional product during the first 30 days, while supplies last, will receive a 2-pack of the product.

Patients participating in the survey will be asked to complete a short questionnaire about their use of the product which will assist the Company in developing or improving its offerings.

Dharmanol Citrolene will be available for sale soon after that through Pharmajanes and many dispensaries throughout California.

Mr. Artemus Mayor, President of SK3 Group said, "Now that our Pharmajanes site is up and running, and we are filling orders for our Dharmanol product, we are pleased to be initiating distribution for this important product through our Pharmajanes platform. While Dharmanol Citrolene will only be available to participants in the promotion for the next several weeks, we intend to have the product available to all qualified patients soon, either through our Pharmajanes platform, or through their local dispensary."

About AEGY

PharmaJanes is an online ordering platform allowing medical marijuana patients to order, process and pay for their authorized needs, in a simple, safe and secure ordering and payment interface. Simple Prepay is a merchant payment solution developed to offer a convenient payment solution to medical cannabis dispensaries, collectives, and delivery services. PharmaJanes also is the exclusive online marketing platform for Medical Greens, a subsidiary of SK3 Group, Inc. (OTC Pink: SKTO).

About SKTO

SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.

FDA Statement

The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ALINA Residences Celebrates Luxury VERIFIED™ Status Award

ALINA Residences: A New Victory in Luxury Living ALINA Residences, located in the heart of Boca Raton, recently snagged the spotlight with its shiny new VERIFIED™ Luxury Residences plaque from Forbes Travel Guide. To most, it might just seem like a piece of metal, but in the world of upscale living, this is a badge of honor. Celebrating Commitment to Service Excellence...

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

Aurora Innovation Faces Supply Chain Hurdles & Legal Scrutiny

Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...

Alignment Healthcare Faces Investigation Over Alleged Fraud

Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...

Hisense's RGB MiniLED TVs: Redefining Halloween Viewing

A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...

STARMUS VIII Merges Science and Art for Change

By Riley Hayes Updated Oct 30, 2026 Category News Views 131

STARMUS VIII: Where Science and Art Collide Think about this: you're basking in the Canary Islands' sun, surrounded by Nobel laureates and astronauts while the riffs of Queen's Sir Brian May soar in the air. That's exactly what went down at STARMUS VIII, a week-long celebration of science and art held in Tenerife and La Palma from October 17 to 22, 2026. A jamboree of...

Highway Motors Deal Reflects Shifts in Auto Trade

A Family Legacy Transitions in Virginia The trucking world doesn't stop spinning, and Highway Motors, an International dealer rooted deep in Virginia's soil since 1929, knows this intimately. This isn't just a back-of-the-napkin sale; it's a strategic move sweeping through the Interstate 81 corridor, touching Winchester, Harrisonburg, Roanoke, and Leesburg locales. What...

Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

FDA Greenlights VELO: A Turning Point for Reynolds?

FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...

BAIC FOTON Eyes Africa for Bold Expansion Moves

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...